Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) FCF Margin (2019 - 2023)

Historic FCF Margin for Benitec Biopharma (BNTC) over the last 5 years, with Q2 2023 value amounting to 58514.29%.

  • Benitec Biopharma's FCF Margin changed N/A to 58514.29% in Q2 2023 from the same period last year, while for Mar 2024 it was 288657.14%, marking a year-over-year decrease of 2610306700.0%. This contributed to the annual value of 24017.33% for FY2023, which is 22187000.0% down from last year.
  • As of Q2 2023, Benitec Biopharma's FCF Margin stood at 58514.29%.
  • In the past 5 years, Benitec Biopharma's FCF Margin registered a high of 9022.86% during Q2 2020, and its lowest value of 347400.0% during Q4 2020.
  • Moreover, its 5-year median value for FCF Margin was 7438.89% (2023), whereas its average is 71591.53%.
  • Per our database at Business Quant, Benitec Biopharma's FCF Margin crashed by 2000000000bps in 2020 and then soared by 2000000000bps in 2021.
  • Quarter analysis of 5 years shows Benitec Biopharma's FCF Margin stood at 3994.81% in 2019, then crashed by -8596bps to 347400.0% in 2020, then skyrocketed by 96bps to 13288.0% in 2021, then crashed by -215bps to 41821.43% in 2022, then plummeted by -40bps to 58514.29% in 2023.
  • Its FCF Margin was 58514.29% in Q2 2023, compared to 7438.89% in Q1 2023 and 41821.43% in Q4 2022.